Ulus Salih AKARCA
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Research areas: Health Sciences, Medicine, Internal Medicine Sciences, Internal Diseases, Gastroenterology and Hepatology, Natural Sciences, Life Sciences, Surgery Medicine Sciences, Fundamental Medical Sciences, Microbiology and Clinical Microbiology
Publications
- siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares (2026)
- TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD) (2026)
- Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial (2026)
- Terlipressin Treatment for Acute Esophageal Variceal Bleeding: Bolus or Infusion? (2025)
- The effects of elafibranor in people with primary biliary cholangitis: a plain language summary (2025)
- Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies (2025)
- Ten‐Year Follow‐Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT‐II): Improved Clinical Outcome After Combination Therapy (2025)
- Frequency, Severity and Impact of Pegylated Interferon Alpha–Associated Flares in Hepatitis D Infection (2025)
- Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study (2025)
- Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye (2025)
- Does aromatherapy massage relieve itching?: A randomised controlled trial (2024)
- Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis (2024)
- TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease (2023)
- The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort. (2023)
- Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries (2023)
- Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa ‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial (2023)
- Comparison of Liver Transplant Outcomes in Biliary Atresia Patients, Considering Whether They Underwent the Kasai Procedure Beforehand: A Single Center Analysis of 72 Patients (2023)
- Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D (2023)
- Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis (2023)
- Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories (2023)
- Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi (2022)
- A single center experience: Liver biopsy results during a year (Liver biopsy results) (2022)
- Characteristics of patients with hepatocellular carcinoma: A multicenter study (2022)
- Eliminating Viral Hepatitis in Turkey: Achievements and Challenges (2022)
- Ten-year single center experience in hepatotoxicity due to mushroom poisoning (2022)
- Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi (2022)
- Randomized controlled study:investigation of the effcet of exercise on liver function tests, fatigue and quality of life in patients with liver cirrhosis (2021)
- Ornidazol ile İlişkili Hepatotoksisite: Son 10 Yılda Hastaneye Yatırılan 24 Hastanın Değerlendirilmesi (2021)
- Kan testi parametrelerinin eklenmesi Fibroscan’ın karaciğer fibrozisini tahmin değerini arttırmamaktadır (2021)
- Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients (2021)
- Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000-20000 IU/ml with ALT 1-2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT (2021)
- Farklı karaciğer hastalıklarında non-invaziv fibrozis göstergelerinin karaciğer biyopsisi ile uyumu ve birbirleriyle Karşılaştırılması (2021)
- Cerrahi prosedürler öncesi anti-HCV taraması: Hastalar yeterince bilgi sahibi mi? (2021)
- Steatotic and Steatohepatitic Hepatocellular Carcinomas (2021)
- The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey (2021)
- Etiology of Cirrhosis in Turkey: A National Cohort Study (2021)
- Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study (2021)
- Otoimmünite ve Gastroenteroloji (2020)
- Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience (2020)
- Nonalkolik yağlı karaciğer hastalığında histolojik progresyon ile klinik ve laboratuvar parametrelerin ilişkisi (2020)
- KARACİĞER TRANSPLANTLI HASTALARDA HEPATİT E VİRÜS IGG SEROPREVELANSI: RETROSPEKTİF TEK MERKEZ DENEYİMİ (2020)
- Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience (2020)
- A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction (2020)
- A micro-elimination approach to addressing hepatitis C in Turkey (2020)
- Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study (2020)
- Nonalkolik yağlı karaciğer hastalığında histolojik progresyon ile klinik ve laboratuvar parametrelerin ilişkisi (2020)
- Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta (2020)
- Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey (2020)
- Çölyak Hastalığında Aile Hekimleri İçin Tanı, Tedavi ve İzlem Rehberi (2019)
- ParitaprevirRitonavirOmbitasvirDasabuvir/-Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience (2019)
- Decrease in HbA1c accounts for the rapid decline in the measurement of liver stiffness by transient elastography in diabetic patients (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- Paritaprevir/Ritonavir/OmbitaSvir/Dasabuvir/Ribavirin treatment in HCV infected chronic hemodialysis patients: a single centereded experience (2019)
- Use of Psycometic tests, Critical flicker frequency test and comparative evaluation of inflamation indicators in the diagnosis of covert hepatic encephalopathy (2019)
- The underwater part of the iceberg: Anti-HCV positivity (2019)
- Epidemiology of Hepatitis Delta Virus Infection in Izmir Turkey: A retrospective cross sectional study (2019)
- HEPATİK ENSEFALOPATİYİ ÖNGÖRDÜRMEDE HEMOGRAM PARAMETRELERİ BİZE NELER SÖYLÜYOR? (2019)
- Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey (2019)
- The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience (2019)
- Can we predict hepatic encephalopathy? What do the hemogram parameters tell us? (2019)
- Epidemiology of hepatitis delta virus infection in İzmir Turkey: A retroppective cross-sectional study (2019)
- A new score based on survival-related variables in patients with decompensated cirrhosis (2019)
- Decrease in HbA1c accounts for the rapid decline in the measurement of liver stiffness by transient elastography in diabetic patients (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- DEKOMPANSE SİROZ HASTALARINDA YAŞAM SÜRESİYLE İLİŞKİLİ DEĞİŞKENLERİN SAPTANMASI (2019)
- Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma: A single center experience in western Turkey. (2019)
- Changing patterns of upper gastrointestinal bleeding over 23 years in Turkey (2019)
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience (2019)
- Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. (2019)
- Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection (2019)
- Hepatit B Virüsü (HBV) Genotip D ile Enfekte Hasta Gruplarında HBV preS1, preS2 ve S Gen Bölgelerinin Analizi (2018)
- Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara (2018)
- Hepatosellüler kanser etyolojisi ve prezentasyon özelliklerinde değişme: Tek merkez deneyimi (2018)
- Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience. (2018)
- Is telbivudine-induced polyneuropathy/myopathy reversible in liver transplant recipients? (2018)
- Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program (2018)
- Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı’nda Son Üç Yılda Yapılmış Kolonoskopi İşlemlerinin Retrospektif İrdelenmesi (2018)
- A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study (2018)
- Results of 1001 liver transplantations in 23 years: Ege University experience (2018)
- Results of 1001 liver transplantations in 23 years: Ege University experience. (2018)
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. (2018)
- Increased Peripheral Platelet Count is Unrelated to Decreased Liver Fibrosis Score Following lamivudine Treatment of Patients with Chronic Hepatitis B (2018)
- LEDIPASVIR/SOFOSBUVIR THERAPY IN GENOTYPE 1 LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV INFECTION: SINGLE CENTER, REAL LIFE EXPERIENCE (2017)
- KRONİK HEPATİT C TEDAVİSİNDE LEDİPASVİR/SOFOSBUVİR: GERÇEK YAŞAM VERİLERİ (2017)
- KRONİK HEPATİT B NEDENİYLE KARACİĞER BİYOPSİ YAPMA ORANININ TRANSİENT ELASTOGRAFİ UYGULAMASINDAN SONRA DEĞİŞİMİ (2017)
- Kronik hepatit C tedavisinde Ledipasvir/Sofosbuvir: Gerçek yaşam verileri. (2017)
- HEMODİYALİZİN FİBROSCAN ÖLÇÜMÜNE ETKİSİ (2017)
- KARACİĞER BİYOPSİSİ VE TRANSİENT ELASTOGRAPHY (FİBROSCAN®) ARASINDAKİ UYUMLA İLİŞKİLİ FAKTÖRLER (2017)
- Böbrek Nakli Hastalarında Hepatit C Virüs Enfeksiyonunun Paritaprevir-Ritonavir-Ombitasvir-Dasavubuvir (prOD) ile Tedavisi (2017)
- EFFICIACY OF LEDİPASVİR AND SOFOSBUVİR WİTH/WİTHOUT TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE RESULT OF A MULTICENTER TURKISH EARLY ACCES PROGRAM (2017)
- KRİPTOJENİK SİROZLARDA YAŞAM SÜRESİ İLE İLİŞKİLİ PARAMETRELER (2017)
- BÖBREK NAKLİHASTALARINDAKİHEPATİT C VİRUS ENFEKSİYONUNUN PARİTAPREVİR-RİTONAVİR-OMBİTASVİRDASABUVİR (PrOD) İLE TEDAVİSİ (2017)
- HEPATİT C ENFEKSİYONUNA BAĞLI DEKOMPANZE SİROZ HASTALARINDA VE KRONİK HEPATİT C ENFEKSİYONU NEDENİYLE KARACİĞER NAKLİ OLANLARDA LEDİPASVİR/SOFOSBUVİR TEDAVİSİNİN ETKİLİLİĞİ: TÜRKİYE ERKEN ERİŞİM PROGRAMI SONUÇLARI (2017)
- YAĞLI KARACİĞER HASTALIĞINDA KARACİĞER FİBROZİSİNİ DEĞERLENDİRMEDE ANLIK ELASTOGRAFİ SONUÇLARI GÜVENİLİR DEĞİLDİR (2017)
- Detectable HBVDNA in liver allograft tissues has no clinical significance on long term follow up in liver transplant recipients under HBIg plus Antiviral prophylaxis (2017)
- Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients? (2017)
- HBV DNA DÜZEYİ<20000 IU/ML OLAN HEPATİT B İNFEKSİYONLU HASTALARDA ELASTOGRAFİNİN DEĞERİ (2017)
- Prognostic Factors for Isolated Locoregional Recurrences in Colon Cancer and Survival After Salvage Surgery: a Cohort Study (2017)